PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-1141.09%
Both yoy net incomes decline, with CRK at -218.67%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-7.68%
Both reduce yoy D&A, with CRK at -4.28%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
110.71%
Some yoy growth while CRK is negative at -201.82%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
171.05%
SBC growth well above CRK's 8.53%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-243.37%
Negative yoy working capital usage while CRK is 74.51%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-25.62%
Both yoy AR lines negative, with CRK at -46.82%. Martin Whitman would suspect an overall sector lean approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-243.37%
Both reduce yoy usage, with CRK at -693.18%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
54.72%
Lower 'other non-cash' growth vs. CRK's 873.73%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
-79.33%
Both yoy CFO lines are negative, with CRK at -22.75%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
68.10%
CapEx growth well above CRK's 37.01%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
40.00%
Acquisition growth of 40.00% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-293.85%
We reduce yoy other investing while CRK is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
21.07%
Investing outflow well above CRK's 37.01%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
56.76%
We repay more while CRK is negative at -768.42%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.